Colorectal Cancer

What is Colorectal Cancer?

Colorectal cancer is a malignant tumor that develops in the colon (large intestine) or rectum, collectively known as the colorectum. It typically begins as small, benign clumps of cells called polyps that can become cancerous over time. This cancer affects both men and women, with incidence rates increasing significantly after age 50. Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer-related deaths, though survival rates are high when detected early.

Key statistics

Symptoms

Common symptoms include persistent changes in bowel habits, blood in stool, abdominal pain, unexplained weight loss, and fatigue.

Early symptoms: Changes in bowel habits lasting more than a few days, including diarrhea, constipation, or feeling that the bowel doesn’t empty completely. Narrow stools may also occur due to partial obstruction.

Common symptoms: Rectal bleeding or blood in stool, which may appear bright red or dark and tarry. Persistent abdominal discomfort, including cramps, gas, or pain. Weakness and fatigue, often accompanied by unexplained weight loss.

Submit Your Paper

Advanced symptoms: Severe abdominal pain, complete bowel obstruction, persistent vomiting, and significant anemia due to chronic blood loss. Jaundice may occur if cancer spreads to the liver.

Causes and risk factors

The exact cause of colorectal cancer involves a combination of genetic mutations and environmental factors. Most cases develop from accumulated DNA damage over time that affects genes controlling cell growth and division.

Genetic factors: Hereditary conditions account for 5-10% of cases, including Lynch syndrome (hereditary nonpolyposis colorectal cancer) and familial adenomatous polyposis (FAP). Having a family history of colorectal cancer or polyps increases risk significantly.

Environmental and lifestyle factors: Diet high in red and processed meats, low fiber intake, excessive alcohol consumption, and smoking all increase risk. Obesity, physical inactivity, and type 2 diabetes are also significant risk factors.

Medical conditions: Inflammatory bowel diseases like ulcerative colitis and Crohn’s disease substantially increase risk. Previous radiation therapy to the abdomen or pelvis for other cancers also elevates risk.

Prevention

Regular screening is the most effective prevention strategy, as it can detect and remove precancerous polyps before they become malignant. Current guidelines recommend screening starting at age 45 for average-risk individuals, with options including colonoscopy every 10 years, flexible sigmoidoscopy every 5 years, or annual fecal immunochemical tests.

Lifestyle modifications: Maintain a healthy diet rich in fruits, vegetables, and whole grains while limiting red and processed meats. Exercise regularly, maintain a healthy weight, limit alcohol consumption, and avoid smoking. Studies suggest that regular aspirin use may reduce risk, though this should be discussed with a healthcare provider due to bleeding risks.

High-risk individuals: Those with family history or genetic predisposition may need earlier and more frequent screening, genetic counseling, and in some cases, prophylactic surgery.

Complications

Without treatment, colorectal cancer can cause complete bowel obstruction, leading to severe pain, vomiting, and inability to pass gas or stool. Perforation of the bowel wall can result in life-threatening peritonitis and sepsis.

The cancer commonly spreads to nearby lymph nodes, liver, lungs, and peritoneum. Liver metastases are particularly common due to the portal circulation system. Advanced disease can cause severe anemia from chronic bleeding, malnutrition from bowel obstruction, and organ failure from widespread metastases.

Treatment-related complications may include surgical complications, chemotherapy side effects such as neuropathy and increased infection risk, and long-term bowel function changes that can significantly impact quality of life.

Diagnosis

Diagnosis typically begins with a thorough medical history and physical examination, including a digital rectal exam. Blood tests may reveal anemia or elevated carcinoembryonic antigen (CEA) levels, though these are not specific for colorectal cancer.

Imaging and procedures: Colonoscopy remains the gold standard for diagnosis, allowing direct visualization and biopsy of suspicious lesions. CT colonography (virtual colonoscopy) may be used when colonoscopy isn’t feasible. Fecal occult blood tests and fecal immunochemical tests can detect hidden blood in stool.

Staging workup: Once cancer is confirmed, CT scans of the chest, abdomen, and pelvis determine the extent of disease. MRI may be used for rectal cancers, and PET scans can help detect distant metastases. Molecular testing of tumor tissue, including microsatellite instability (MSI) and KRAS/BRAF mutations, guides treatment decisions.

Treatment

Treatment depends on cancer stage, location, and patient factors. Surgery remains the primary curative treatment for localized disease.

Surgical options: Colon resection involves removing the tumor and surrounding healthy tissue along with nearby lymph nodes. For rectal cancer, options include low anterior resection or abdominoperineal resection, which may require a permanent colostomy.

Chemotherapy: Common regimens include fluorouracil combined with leucovorin, often with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI). Capecitabine may be used as an oral alternative.

Targeted therapies: Bevacizumab targets blood vessel formation, while cetuximab and panitumumab target EGFR in specific genetic subtypes. Pembrolizumab and nivolumab are immunotherapy options for MSI-high tumors.

Radiation therapy: Primarily used for rectal cancer, either before surgery to shrink tumors or after surgery to reduce recurrence risk.

Prognosis

Prognosis varies significantly by stage at diagnosis. The overall 5-year survival rate is approximately 65%, but this ranges from over 90% for localized disease to about 15% for distant metastases.

Stage-specific outcomes: Stage I and II cancers have excellent prognoses with appropriate treatment, with 5-year survival rates exceeding 85%. Stage III disease, involving regional lymph nodes, has a 5-year survival rate of 60-70%. Stage IV disease with distant metastases has a median survival of 2-3 years, though some patients achieve long-term survival with aggressive treatment.

Factors affecting prognosis include tumor location (rectal cancers often have worse outcomes), histologic grade, molecular characteristics, and patient age and overall health. Early detection through screening programs has significantly improved overall outcomes.

Quality of life

Living with colorectal cancer involves managing both disease-related symptoms and treatment side effects. Many patients maintain good quality of life with appropriate support and management strategies.

Dietary considerations: Work with a registered dietitian to manage nutrition during treatment. Small, frequent meals may help with nausea, while high-fiber foods should be introduced gradually post-surgery. Stay hydrated and consider nutritional supplements if recommended.

Physical activity: Regular exercise, as tolerated, can improve fatigue, mood, and overall well-being. Start slowly and gradually increase activity levels with medical clearance.

Emotional support: Cancer diagnosis and treatment can cause anxiety, depression, and fear of recurrence. Professional counseling, support groups, and stress management techniques like meditation can be beneficial. Many cancer centers offer comprehensive psychosocial support services.

Practical adjustments: Colostomy care education is essential for those requiring permanent stomas. Workplace accommodations may be needed during treatment. Financial counseling can help manage treatment costs and insurance issues.

Pregnancy and fertility

Colorectal cancer during pregnancy is rare but requires specialized multidisciplinary care balancing maternal treatment needs with fetal safety. Surgery can often be safely performed during pregnancy, particularly in the second trimester.

Chemotherapy timing depends on gestational age, with many agents contraindicated in the first trimester due to teratogenic risks. Some treatments may be safely administered in the second and third trimesters under careful monitoring.

Fertility considerations: Chemotherapy and radiation can affect fertility in both men and women. Fertility preservation options, including sperm banking, egg freezing, or ovarian tissue preservation, should be discussed before treatment begins. Genetic counseling is recommended for hereditary colorectal cancer syndromes to discuss inheritance risks.

Children

Colorectal cancer is extremely rare in children, typically occurring only in the context of hereditary cancer syndromes like familial adenomatous polyposis or Lynch syndrome.

Children with these conditions require specialized pediatric gastroenterology care with regular surveillance starting in adolescence. FAP patients may need prophylactic colectomy in their teens or early twenties.

Family considerations: Children of parents with hereditary colorectal cancer syndromes may benefit from genetic counseling and age-appropriate education about their potential risk. Transition planning to adult care is crucial for adolescents with hereditary conditions.

When to see a doctor

Seek immediate medical attention for severe abdominal pain, signs of bowel obstruction (inability to pass gas or stool, severe bloating, vomiting), or significant rectal bleeding with dizziness or weakness.

Schedule routine medical care for persistent changes in bowel habits lasting more than two weeks, blood in stool, unexplained weight loss, or persistent abdominal discomfort. Don’t delay screening if you’re over 45 or have risk factors requiring earlier screening.

Emergency symptoms: Severe dehydration, signs of infection (fever, chills), severe bleeding, or any symptoms that cause significant concern warrant immediate medical evaluation.

Regional context

Colorectal cancer incidence in the Caucasus region varies by country, with Armenia and Georgia showing increasing rates that parallel Western dietary changes and lifestyle factors. Access to screening programs remains limited in some areas, contributing to later-stage diagnoses.

Regional dietary patterns, including increased consumption of processed foods and decreased physical activity, may be contributing to rising incidence rates. Healthcare infrastructure improvements are ongoing to expand access to colonoscopy and other screening modalities.

GMJ welcomes contributions from regional researchers to build the evidence base for colorectal cancer prevention and treatment strategies specific to Caucasus populations.

Research and clinical trials

Current research focuses on personalized medicine approaches, including liquid biopsies for early detection and monitoring treatment response. Immunotherapy combinations and novel targeted therapies show promise for advanced disease.

Artificial intelligence applications in colonoscopy screening are improving polyp detection rates. Research into the gut microbiome’s role in colorectal cancer development may lead to new prevention and treatment strategies.

Clinical trial opportunities: Patients should discuss clinical trial eligibility with their oncologist. ClinicalTrials.gov provides comprehensive information about ongoing studies, including trials for prevention, treatment, and supportive care interventions.

Frequently asked questions

Can colorectal cancer be prevented?

While not entirely preventable, risk can be significantly reduced through regular screening, maintaining a healthy lifestyle with a high-fiber diet, regular exercise, avoiding smoking, and limiting alcohol consumption.

How often should I be screened?

Average-risk individuals should begin screening at age 45, with colonoscopy every 10 years or alternative methods like annual fecal immunochemical tests. Those with family history or other risk factors may need earlier and more frequent screening.

What’s the difference between colon and rectal cancer treatment?

Rectal cancers often require radiation therapy in addition to surgery and chemotherapy due to their location in the pelvis. Treatment may also be more likely to result in permanent colostomy compared to colon cancers.

Will I need a colostomy?

Most colon cancer surgeries do not require permanent colostomy. Temporary colostomies may be needed to allow healing, but permanent ones are typically only required for very low rectal cancers or emergency situations.

Can I work during treatment?

Many patients continue working during treatment with accommodations. Discuss your work demands with your healthcare team to plan treatment timing and workplace modifications as needed.

Support and resources

International organizations:
– Colorectal Cancer Alliance (https://www.colorectalcancer.org)
– Fight Colorectal Cancer (https://fightcolorectalcancer.org)
– World Cancer Research Fund (https://www.wcrf.org)
– International Agency for Research on Cancer (https://www.iarc.who.int)

Professional organizations:
– American Society of Clinical Oncology (ASCO)
– European Society for Medical Oncology (ESMO)
– World Gastroenterology Organisation

Support services: Many cancer centers offer comprehensive support including nutrition counseling, social work services, support groups, and palliative care consultation.

Related conditions

Familial Adenomatous Polyposis – Hereditary condition causing hundreds of polyps in the colon and rectum, with near 100% cancer risk if untreated.

Lynch Syndrome – Most common hereditary colorectal cancer syndrome, also increasing risk for endometrial, ovarian, and other cancers.

Inflammatory Bowel Disease – Including Crohn’s disease and ulcerative colitis, which significantly increase colorectal cancer risk.

Adenomatous Polyps – Precancerous growths in the colon that can develop into colorectal cancer over time.

Hereditary Cancer Syndromes – Various genetic conditions that predispose to multiple cancer types including colorectal cancer.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.

Licensed under CC BY 4.0. Free to share with attribution to GMJ News.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.